Apt Pharmaceutical Private Limited
About Apt Pharmaceutical Private Limited
Data last updated:
Apt Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 July 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2022PTC387785.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Purshottam Dattatraya Yedurkar and Anita Purshottam Yedurkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala 23 Pragati Industrial Estate N.M. Joshi Marg Lower Parel, Mumbai, Maharashtra, India – 400011.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Cr, a growth of 116% compared to the previous year. For the same year it recorded a net profit of ₹6.94 Lakh (net margin 2.6%) and EBITDA of ₹9.76 Lakh (EBITDA margin 3.7%).
As per MCA filings, the company has open charges of ₹1 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGala 23 Pragati Industrial Estate N.M. Joshi Marg Lower Parel, Mumbai, Maharashtra, India – 400011
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Apt Pharmaceutical Private Limited
The main business activity of Apt Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Apt Pharmaceutical Private Limited FY 2025 filings available
Apt Pharmaceutical Private Limited reported revenue of ₹2.66 Cr (up 116% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Apt Pharmaceutical Private Limited
Revenue rose 116% in the latest year. EBITDA rose 1% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Apt Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹9.76 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.94 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Apt Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.7% | •••• | •••• |
| Net Profit Margin | 2.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apt Pharmaceutical are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Apt Pharmaceutical Private Limited
Apt Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Agriculture industry (Pesticides). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pona Lab Biogrowth Private Limited | ₹2.73 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Bangalore, Karnataka, India |
| Ramachandra Pesticides Limited | ₹2.72 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Bangalore, Karnataka, India |
| Verma Pesticides & Pest Control Services Private Limited | ₹2.7 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Delhi, India |
| Galaxie Agritech Private Limited | ₹2.68 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Delhi, India |
| Samarth Bio-Tech Limited | ₹2.66 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Hubli, Karnataka, India |
| Apt Pharmaceutical Private Limited this company | ₹2.66 Cr (FY 2025) | •••• | •••• | 116.0% | •••• | Mumbai, Maharashtra, India |
| Vista Agrigreen Private Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
| Mars Fertichem Limited | ₹2.65 Cr (FY 2025) | •••• | •••• | 8717.0% | •••• | Indore, Madhya Pradesh, India |
| Indore Cooltronics Private Limited | ₹2.64 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Indore, Madhya Pradesh, India |
| Ozone Organics Private Limited | ₹2.6 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Hyderabad, Telangana, India |
| Hindustan Pesticides Agrochemicals Private Limited | ₹2.58 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Apt Pharmaceutical by revenue in the Agriculture industry (Pesticides), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Apt Pharmaceutical Private Limited
Apt Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Purshottam Dattatraya Yedurkar | Director | 28 Jul 2022 | 4 Years 2 Months | Current |
| Anita Purshottam Yedurkar | Director | 28 Jul 2022 | 4 Years 2 Months | Current |
Charges & Borrowings of Apt Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2024 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Apt Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Apt Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Apt Pharmaceutical Private Limited
Apt Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Anita Purshottam Yedurkar was appointed as Director on 28 Jul 2022.
Credit Ratings, Litigation & Regulatory Alerts for Apt Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apt Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apt Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Apt Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apt Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apt Pharmaceutical Private Limited
Apt Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 July 2022 (4+ years old) and is registered under CIN U24239MH2022PTC387785.
Apt Pharmaceutical reported revenue of ₹2.66 Cr for FY 2025 (up 116% YoY).
Apt Pharmaceutical has 2 current directors:
- Purshottam Dattatraya Yedurkar - Director
- Anita Purshottam Yedurkar - Director
Apt Pharmaceutical reported a net profit of ₹6.94 Lakh (net margin 2.6%) and EBITDA of ₹9.76 Lakh (EBITDA margin 3.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Apt Pharmaceutical is U24239MH2022PTC387785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apt Pharmaceutical was incorporated on 28 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Apt Pharmaceutical by revenue are Pona Lab Biogrowth Private Limited, Ramachandra Pesticides Limited, Verma Pesticides & Pest Control Services Private Limited, Galaxie Agritech Private Limited, Samarth Bio-Tech Limited and 5 more, all in the Agriculture industry (Pesticides).
Anita Purshottam Yedurkar was appointed as Director on 28 Jul 2022. Purshottam Dattatraya Yedurkar was appointed as Director on 28 Jul 2022.
Yes, Apt Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Apt Pharmaceutical is at Gala 23 Pragati Industrial Estate N.M. Joshi Marg Lower Parel, Mumbai, Maharashtra, India – 400011.
Apt Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.